A MULTICENTER, RANDOMIZED, OPEN LABEL STUDY TO EVALUATE THE LIPID LOWERING EFFICACY AND SAFETY OF VYTORIN® 10/20 VS. ATORVASTATIN 10MG IN HYPERCHOLESTEROLEMIA PATIENTS WITH METABOLIC SYNDROME IN KOREA (0653A-129)(COMPLETED):